Given the data presented herein, it is likely that this mutually exclusive relationship between DIEXF and TP53 is driven by amplification of MDM4. We cannot, however, exclude the possibility that overexpression of DIEXF contributes to p53 pathway attenuation in these cancers. Here, MDM4 is linked to cancer.